Avalo Therapeutics (AVTX) Revenue & Revenue Breakdown
Avalo Therapeutics Revenue Highlights
Latest Revenue (Y)
$441.00K
Main Segment (Y)
Product
Avalo Therapeutics Revenue by Period
Avalo Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $441.00K | -77.08% |
| 2023-12-31 | $1.92M | -89.34% |
| 2022-12-31 | $18.05M | 234.40% |
| 2021-12-31 | $5.40M | -19.42% |
| 2020-12-31 | $6.70M | -0.76% |
| 2019-12-31 | $6.75M | -63.17% |
| 2018-12-31 | $18.33M | -34.11% |
| 2017-12-31 | $27.81M | 2312.24% |
| 2016-12-31 | $1.15M | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | -100.00% |
| 2012-12-31 | $82.76K | - |
Avalo Therapeutics generated $441.00K in revenue during NA 2024, up -77.08% compared to the previous quarter, and up 6.53% compared to the same period a year ago.
Avalo Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $192.00K | -22.89% |
| 2024-09-30 | $249.00K | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $571.00K | 141.95% |
| 2023-09-30 | $236.00K | -63.30% |
| 2023-06-30 | $643.00K | 35.37% |
| 2023-03-31 | $475.00K | -46.99% |
| 2022-12-31 | $896.00K | -94.01% |
| 2022-09-30 | $14.95M | 1347.14% |
| 2022-06-30 | $1.03M | -11.94% |
| 2022-03-31 | $1.17M | 435.62% |
| 2021-12-31 | $219.00K | -83.78% |
| 2021-09-30 | $1.35M | -59.76% |
| 2021-06-30 | $3.35M | 609.30% |
| 2021-03-31 | $473.00K | -68.39% |
| 2020-12-31 | $1.50M | 34.70% |
| 2020-09-30 | $1.11M | -16.97% |
| 2020-06-30 | $1.34M | -51.42% |
| 2020-03-31 | $2.75M | -131.57% |
| 2019-12-31 | $-8.72M | -255.41% |
| 2019-09-30 | $5.61M | 26.16% |
| 2019-06-30 | $4.45M | -17.78% |
| 2019-03-31 | $5.41M | 8.57% |
| 2018-12-31 | $4.98M | 22.32% |
| 2018-09-30 | $4.07M | -14.84% |
| 2018-06-30 | $4.79M | 6.74% |
| 2018-03-31 | $4.48M | 100.70% |
| 2017-12-31 | $2.23M | -91.08% |
| 2017-09-30 | $25.04M | 15766.66% |
| 2017-06-30 | $157.80K | -58.93% |
| 2017-03-31 | $384.21K | 111.10% |
| 2016-12-31 | $182.00K | -43.39% |
| 2016-09-30 | $321.50K | -50.58% |
| 2016-06-30 | $650.49K | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | - |
Avalo Therapeutics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Avalo Therapeutics Revenue Breakdown
Avalo Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Product | $441.00K | $1.41M | $3.36M | $4.77M | $6.70M |
| License | - | $516.00K | $14.69M | $625.00K | - |
Latest
Avalo Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 24 | Sep 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Sep 19 | Jun 19 | Mar 19 | Dec 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $192.00K | $249.00K | $54.00K | $236.00K | $643.00K | $475.00K | $726.00K | $432.00K | $1.03M | $1.17M | $219.00K | $1.35M | $2.73M | $473.00K | $1.50M | $1.11M | - | - | - | - |
| License | - | - | - | - | $170.00K | $14.52M | - | - | - | $625.00K | - | $100.00K | - | - | - | - | - | - | - | - |
| Prescribed Dietary Supplements | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.32M | $1.80M | $1.79M | $1.91M |
| Prescription Drugs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.19M | $2.65M | $3.62M | $2.91M |
| Sales Force Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $159.18K |
| Sales Revenue, Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.51M | $4.45M | $5.41M | $4.82M |
Latest
Avalo Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).